Article citationsMore>>

Conselho Federal de Farmácia (CFF) (2023). Tizerpatida: Anvisa aprova novo medicamento promissor para o tratamento de diabetes tipo 2.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top